178 related articles for article (PubMed ID: 8015766)
1. Tumor markers in epithelial ovarian cancer. Clinical applications.
Hempling RE
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers in the monitoring of ovarian cancer].
Xu SX
Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):345-7, 383. PubMed ID: 2282861
[TBL] [Abstract][Full Text] [Related]
3. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
Yue K; Bian M; Zhu D; Liu W; Siu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
Vardi JR; Tadros GH; Foemmel R; Shebes M
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
[TBL] [Abstract][Full Text] [Related]
5. The importance of polyamine determination in monitoring malignant gynaecological tumours.
Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
[TBL] [Abstract][Full Text] [Related]
6. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
[TBL] [Abstract][Full Text] [Related]
7. [Tumor markers in epithelial ovarian cancer].
Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
[TBL] [Abstract][Full Text] [Related]
8. The significance of neopterin determination as a tumour marker in ovarian cancer.
Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
[TBL] [Abstract][Full Text] [Related]
9. Circulating mucins as tumor markers in ovarian cancer (review).
Devine PL; McGuckin MA; Ward BG
Anticancer Res; 1992; 12(3):709-17. PubMed ID: 1622128
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
Ito K; Udagawa Y; Nozawa S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
[TBL] [Abstract][Full Text] [Related]
11. A case control study of glycoprotein status in ovarian carcinoma.
Aranganathan S; Senthil K; Nalini N
Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
[TBL] [Abstract][Full Text] [Related]
12. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
13. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of CA-125 in epithelial ovarian cancer patients during and after chemotherapy.
Lukácskó I; Hernádi Z; Sápy T; Borsos A
Acta Chir Hung; 1997; 36(1-4):213-4. PubMed ID: 9408350
[TBL] [Abstract][Full Text] [Related]
15. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary].
Gadducci A; Ferdeghini M; Prato B; Bartolini T; Nicolini A; Scatena P; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1985; 106(1):34-9. PubMed ID: 2994537
[No Abstract] [Full Text] [Related]
17. Quantitative detection of serum survivin and its relationship with prognostic factors in ovarian cancer.
No JH; Jeon YT; Kim YB; Song YS
Gynecol Obstet Invest; 2011; 71(2):136-40. PubMed ID: 21160138
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers in ovarian cancer.
Kiricuta I; Bojan O; Munteanu S
Arch Geschwulstforsch; 1986; 56(1):35-8. PubMed ID: 3964031
[TBL] [Abstract][Full Text] [Related]
19. [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
Sevelda P; Rosen A; Barrada M; Gober S; Vavra N; Salzer H
Gynakol Rundsch; 1990; 30 Suppl 1():210-1. PubMed ID: 2079273
[No Abstract] [Full Text] [Related]
20. Combination of markers may prove useful in screening for ovarian CA.
Oncology (Williston Park); 1994 Jun; 8(6):79-80. PubMed ID: 8074986
[No Abstract] [Full Text] [Related]
[Next] [New Search]